Literature DB >> 7220676

Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs.

R Zimmer, A W Teelken, K D Meier, M Ackenheil, K J Zander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7220676     DOI: 10.1016/0364-7722(81)90103-x

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol        ISSN: 0364-7722


× No keyword cloud information.
  5 in total

1.  Elevated gamma-aminobutyric acid levels in chronic schizophrenia.

Authors:  Dost Ongür; Andrew P Prescot; Julie McCarthy; Bruce M Cohen; Perry F Renshaw
Journal:  Biol Psychiatry       Date:  2010-07-02       Impact factor: 13.382

2.  In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.

Authors:  Matthew D Puhl; Dionyssios Mintzopoulos; J Eric Jensen; Timothy E Gillis; Glenn T Konopaske; Marc J Kaufman; Joseph T Coyle
Journal:  Neurobiol Dis       Date:  2014-10-23       Impact factor: 5.996

Review 3.  Central GABAergic systems and depressive illness.

Authors:  G Tunnicliff; E Malatynska
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

4.  Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results.

Authors:  Ursula M H Klumpers; Dick J Veltman; Madeleine L Drent; Ronald Boellaard; Emile F I Comans; Gerben Meynen; Adriaan A Lammertsma; Witte J G Hoogendijk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-05       Impact factor: 9.236

5.  CSF GABA is reduced in first-episode psychosis and associates to symptom severity.

Authors:  F Orhan; H Fatouros-Bergman; M Goiny; A Malmqvist; F Piehl; S Cervenka; K Collste; P Victorsson; C M Sellgren; L Flyckt; S Erhardt; G Engberg
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.